FDA Inspection 1114311 — Glaxosmithkline ConsumerHealthcare Holdings LLC DBA HALEON GROUP
The FDA completed an inspection of Glaxosmithkline ConsumerHealthcare Holdings LLC DBA HALEON GROUP on October 31, 2019 in Carlisle, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Food/Cosmetics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- October 31, 2019
- Fiscal Year
- 2020
- Product Type
- Food/Cosmetics
- Project Area
- Foodborne Biological Hazards
- Location
- Carlisle, PA (United States)